Home » Topics » Musculoskeletal, BioWorld Science

Musculoskeletal, BioWorld Science
RSS

New hydroxamic acid compounds inhibiting TNF, PDE IV and/or MMPs

Sep. 11, 1997

Promising preliminary results obtained with Arthrovas in osteoarthritis

Sep. 10, 1997

Boehringer Mannheim prepares MMP inhibitors

Sep. 8, 1997

Anika completes phase III trial on Orthovisc

Sep. 4, 1997

New MMP and TNF inhibitor from Kanebo

Sep. 2, 1997

Hyalgan introduced in U.S. for osteoarthritis of the knee

Sep. 1, 1997

Pharos receives patent for novel method of controlling and treating inflammation

Aug. 29, 1997

Stromelysin inhibitors: New approach to treating arthritis?

Aug. 29, 1997

Familial Mediterranean fever gene discovered

Aug. 28, 1997

MMP inhibitors effective in rat model of arthritis

Aug. 26, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...